http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106834217-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-905 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-32 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0625 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0605 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
filingDate | 2017-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106834217-B |
titleOfInvention | Method for promoting in-vitro amplification of human amniotic epithelial cells and application |
abstract | The invention relates to a method for promoting the in vitro amplification of human amniotic epithelial cells, which is characterized in that a nutrition combination is added in the culture process of the human amniotic epithelial cellsThe nutrient composition mainly comprises hyaluronic acid, epidermal growth factor, vitamin C, GlutaMAX-, β The human amniotic epithelial cell proliferation promoter can obviously promote the proliferation of the human amniotic epithelial cells, reduce the doubling time, maintain the biological characteristics of cell surface marker expression, multidirectional differentiation potential, immune tolerance and the like of the human amniotic epithelial cells, and also can obviously enhance the expression levels of human amniotic epithelial cell dryness-related genes and immunosuppressive factors. Therefore, the nutritional composition has obvious advantages and characteristics as the human amniotic epithelial cell proliferation regulator, and has important clinical significance for relieving the shortage of the number of seed cells in the field of regenerative medicine. |
priorityDate | 2017-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.